REMEGEN (09995) spent 20.04 million yuan to repurchase 194,100 A-shares on January 20th.
Rongchang Biology (09995) announced that on January 20, 2026, the company repurchased 194,100 shares of its own shares through the trading system of the Shanghai Stock Exchange by centralized bidding, accounting for 0.0344% of the total share capital of the company, which is 564 million shares. The highest price for the repurchase was RMB 103.78 per share, the lowest price was RMB 102.17 per share, and the total amount paid was RMB 20.04 million (excluding transaction costs).
REMEGEN (09995) announced that on January 20, 2026, the company repurchased 194,100 shares of its own stock through the trading system of the Shanghai Stock Exchange by way of centralized competitive bidding, representing 0.0344% of the total share capital of the company of 564 million shares. The highest price for the repurchase transaction was RMB 103.78 per share and the lowest price was RMB 102.17 per share, with a total amount paid of RMB 20.04 million (excluding transaction costs).
As of January 20, 2026, the company has repurchased a total of 194,100 shares of its own stock through the trading system of the Shanghai Stock Exchange by way of centralized competitive bidding, representing 0.0344% of the total share capital of the company. The highest price for the repurchase transaction was RMB 103.78 per share and the lowest price was RMB 102.17 per share, with a total amount paid of RMB 20.04 million (excluding transaction costs). The company's share repurchase has reached the lower limit of the repurchase fund total amount, and there has been no exceeding of the upper limit of the repurchase fund total amount. The repurchase plan has been fully implemented.
Related Articles

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families






